» Articles » PMID: 33684520

Bacterial and Fungal Co-infections Among COVID-19 Patients in Intensive Care Unit

Overview
Journal Microbes Infect
Publisher Elsevier
Date 2021 Mar 8
PMID 33684520
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to investigate the frequency and characteristics of respiratory co-infections in COVID-19 patients in the intensive care unit (ICU). In this retrospective observational study, pathogens responsible for potential co-infections were detected by the bacterial culture, real-time polymerase chain reaction (RT-PCR), or serological fungal antigen tests. Demographic and clinical characteristics, as well as microbial results, were analyzed. Bacterial culture identified 56 (58.3%) positive samples for respiratory pathogens, with the most common bacteria being Burkholderia cepacia (18, 18.8%). RT-PCR detected 38 (76.0%) and 58 (87.9%) positive results in the severe and critical groups, respectively. Most common pathogens detected were Stenotrophomonas maltophilia (28.0%) and Pseudomonas aeruginosa (28.0%) in the severe group and S. maltophilia (45.5%) in the critical group. P. aeruginosa was detected more during the early stage after ICU admission. Acinetobacter baumannii and Staphylococcus aureus were more frequently identified during late ICU admission. Fungal serum antigens were more frequently positive in the critical group than in the severe group, and the positive rate of fungal serum antigens frequency increased with prolonged ICU stay. A high frequency of respiratory co-infections presented in ICU COVID-19 patients. Careful examinations and necessary tests should be performed to exclude these co-infections.

Citing Articles

Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children.

Hoshino W, da Silva A, Pignatari A, Gales A, Carlesse F Braz J Infect Dis. 2025; 29(2):104515.

PMID: 39985933 PMC: 11893299. DOI: 10.1016/j.bjid.2025.104515.


Secondary Bacterial Infections in Critically Ill COVID-19 Patients Admitted in the Intensive Care Unit of a Tertiary Hospital in Romania.

Pintea-Simon I, Bancu L, Mare A, Ciurea C, Toma F, Brukner M J Clin Med. 2024; 13(20).

PMID: 39458151 PMC: 11508343. DOI: 10.3390/jcm13206201.


Mortality in hospitalized SARS-CoV-2 patients with contemporaneous bacterial and fungal infections.

Hanna J, Most Z, Cooper L, Wakene A, Radunsky A, Lehmann C Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e142.

PMID: 39346658 PMC: 11428019. DOI: 10.1017/ash.2024.424.


Genomic Insights into Vietnamese Extended-Spectrum β-Lactamase-9-Producing Extensively Drug-Resistant Isolates Belonging to the High-Risk Clone ST357 Obtained from Bulgarian Intensive Care Unit Patients.

Strateva T, Stratev A, Peykov S Pathogens. 2024; 13(9).

PMID: 39338911 PMC: 11435151. DOI: 10.3390/pathogens13090719.


Co-Infection of SARS-CoV-2 and : A Systematic Review and Meta-Analysis.

Chagas A, Araujo J, Serra J, Araujo K, Cunha M, Correia A Diagnostics (Basel). 2024; 14(11).

PMID: 38893674 PMC: 11171625. DOI: 10.3390/diagnostics14111149.